









市场行情
/
股票
/
nasdaq-evh
/

Evolent Health Inc

EVH

4.310USD

+0.040+0.94%

收盘 11/25, 16:00（美东）报价延迟15分钟

480.96M总市值

亏损市盈率 TTM



Evolent Health Inc

4.310

+0.040+0.94%

概览公司财务分析

概览

公司

财务

分析

关于 Evolent Health Inc 公司

Evolent Health, Inc. 是一家医疗保健公司，为患有癌症、心血管疾病和肌肉骨骼疾病等复杂疾病的人提供医疗服务。该公司提供三种主要解决方案：专科护理管理服务、总护理成本管理和行政服务。该公司为肿瘤和心脏病患者提供全面的质量管理，从诊断到提前护理计划服务，以及为门诊骨科手术确定优质、最低成本的护理。其总护理成本管理解决方案使提供商能够管理他们可能根据与付款人签订的价值型合同或与医疗保险和医疗补助服务中心 (CMS) 签订的责任医疗组织 (ACO) 合同负责的人群。其行政服务解决方案包括集成的价值型护理平台，旨在帮助客户以经济高效的方式管理和管理患者健康。

Evolent Health Inc简介



公司代码EVH

公司名称Evolent Health Inc

上市日期Jun 05, 2015

CEOMr. Seth Blackley

员工数量4500

证券类型Ordinary Share

年结日Jun 05

公司地址1812 North Moore St, Suite 1705

城市ARLINGTON

上市交易所NYSE Consolidated

国家United States of America

邮编22209

电话15713896000

网址https://www.evolent.com/

公司代码EVH

上市日期Jun 05, 2015

CEOMr. Seth Blackley

Evolent Health Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Seth Blackley

Chief Executive Officer, Co-Founder, Director

508.13K

+15.23%

Mr. John Paul Johnson

Chief Strategy Officer

184.49K

+16.01%

Mr. Peter J. Grua

Independent Director

82.65K

+36.23%

Ms. Cheryl M. Scott

Independent Director

73.48K

+42.68%

Mr. Richard M. Jelinek

Independent Chairman of the Board

66.44K

+49.44%

Ms. Kim Keck

Independent Director

61.50K

+55.61%

Mr. Aammaad Shams

Chief Accounting Officer

55.40K

-4.43%

Mr. Craig A. Barbarosh

Independent Director

53.94K

+68.78%

Dr. Toyin Ajayi, M.D.

Independent Director

34.07K

+181.72%

Mr. Shawn M. Guertin

Director

21.98K

名称

名称/职务

职务

持股

持股变动

Mr. Seth Blackley

Chief Executive Officer, Co-Founder, Director

508.13K

+15.23%

Mr. John Paul Johnson

Chief Strategy Officer

184.49K

+16.01%

Mr. Peter J. Grua

Independent Director

82.65K

+36.23%

Ms. Cheryl M. Scott

Independent Director

73.48K

+42.68%

Mr. Richard M. Jelinek

Independent Chairman of the Board

66.44K

+49.44%

Ms. Kim Keck

Independent Director

61.50K

+55.61%

收入明细

单位: USD更新时间: 2月24日周一

FY2021

FY2020

FY2019

业务USD

名称

营收

占比

Platform and operations

896.75M

98.77%

Transformation services

11.20M

1.23%

由于公司未披露，未能获取相关数据

业务

地区

业务USD

名称

营收

占比

Platform and operations

896.75M

98.77%

Transformation services

11.20M

1.23%

股东统计

更新时间: 11月18日周二

持股股东

股东类型

持股股东

占比

Cadian Capital Management LP

10.51%

The Vanguard Group, Inc.

9.81%

BlackRock Institutional Trust Company, N.A.

7.04%

Fidelity Management & Research Company LLC

6.88%

Morgan Stanley & Co. LLC

6.71%

其他

59.05%

持股股东

占比

Cadian Capital Management LP

10.51%

The Vanguard Group, Inc.

9.81%

BlackRock Institutional Trust Company, N.A.

7.04%

Fidelity Management & Research Company LLC

6.88%

Morgan Stanley & Co. LLC

6.71%

其他

59.05%

股东类型

持股股东

占比

Investment Advisor

51.75%

Hedge Fund

33.00%

Investment Advisor/Hedge Fund

25.97%

Research Firm

11.11%

Individual Investor

1.68%

Venture Capital

0.61%

Pension Fund

0.60%

Bank and Trust

0.43%

Sovereign Wealth Fund

0.16%

机构持股



更新时间: 10月1日周三

报告期

机构数

持股数

持股占比

持股变动

2025Q3

583

129.03M

115.62%

-25.34M

2025Q2

591

129.14M

110.03%

-13.77M

2025Q1

622

133.55M

113.84%

-13.20M

2024Q4

617

129.23M

110.86%

-26.99M

2024Q3

604

139.74M

121.52%

-23.43M

2024Q2

570

138.51M

120.74%

-16.12M

2024Q1

562

134.93M

117.72%

-21.70M

2023Q4

551

135.59M

118.01%

-17.32M

2023Q3

543

130.97M

115.67%

-18.07M

2023Q2

540

125.90M

111.75%

-15.65M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Cadian Capital Management LP

10.42M

8.87%

-369.90K

-3.43%

Jun 30, 2025

The Vanguard Group, Inc.

10.90M

9.28%

-16.63K

-0.15%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

7.75M

6.59%

-36.76K

-0.47%

Jun 30, 2025

Fidelity Management & Research Company LLC

6.37M

5.42%

+3.17M

+98.79%

Jun 30, 2025

Morgan Stanley & Co. LLC

7.35M

6.26%

+4.38M

+147.31%

Jun 30, 2025

Eventide Asset Management, LLC

4.09M

3.48%

-1.99M

-32.75%

Jun 30, 2025

Engaged Capital, LLC

5.85M

4.98%

+675.00K

+13.03%

Jun 30, 2025

William Blair Investment Management, LLC

4.32M

3.68%

-79.05K

-1.80%

Jun 30, 2025

UBS Financial Services, Inc.

2.81M

2.39%

+269.54K

+10.60%

Jun 30, 2025

持股ETF



更新时间: 11月6日周四

机构名称

占比

Fidelity Digital Health ETF

1.14%

Global X HealthTech ETF

0.93%

JPMorgan Fundamental Data Science Small Core ETF

0.2%

Optimize Strategy Index ETF

0.19%

iShares U.S. Healthcare Providers ETF

0.16%

Avantis US Small Cap Equity ETF

0.09%

Invesco RAFI US 1500 Small-Mid ETF

0.08%

SPDR S&P Kensho New Economies Composite ETF

0.08%

iShares Russell 2000 Value ETF

0.05%

JPMorgan BetaBuilders US Small Cap Equity ETF

0.05%

Fidelity Digital Health ETF

占比1.14%

Global X HealthTech ETF

占比0.93%

JPMorgan Fundamental Data Science Small Core ETF

占比0.2%

Optimize Strategy Index ETF

占比0.19%

iShares U.S. Healthcare Providers ETF

占比0.16%

Avantis US Small Cap Equity ETF

占比0.09%

Invesco RAFI US 1500 Small-Mid ETF

占比0.08%

SPDR S&P Kensho New Economies Composite ETF

占比0.08%

iShares Russell 2000 Value ETF

占比0.05%

JPMorgan BetaBuilders US Small Cap Equity ETF

占比0.05%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Evolent Health Inc的前五大股东是谁？



Evolent Health Inc 的前五大股东如下：
Cadian Capital Management LP持有股份：10.42M，占总股份比例：8.87%。
The Vanguard Group, Inc.持有股份：10.90M，占总股份比例：9.28%。
BlackRock Institutional Trust Company, N.A.持有股份：7.75M，占总股份比例：6.59%。
Fidelity Management & Research Company LLC持有股份：6.37M，占总股份比例：5.42%。
Morgan Stanley & Co. LLC持有股份：7.35M，占总股份比例：6.26%。